Get Your Personalized Supplement StackSupplement Stack Quiz

Saccharomyces Turicensis

Q: How long does it take to see benefits from Saccharomyces boulardii?

Benefits are typically observed during the course of treatment, particularly when used preventatively during antibiotic use or to manage gastrointestinal symptoms.

Q: Can Saccharomyces boulardii be used with antibiotics?

Yes, it is often used to prevent antibiotic-associated diarrhea (AAD). It helps to maintain gut flora balance during antibiotic treatment.

Q: Is Saccharomyces boulardii safe for immunocompromised patients?

Generally, it is not recommended for severely immunocompromised patients due to a rare risk of fungemia. Caution is advised in such cases.

Q: When is the best time to take Saccharomyces boulardii?

It is best taken during or shortly after meals to enhance its survival and activity in the gastrointestinal tract.

Q: What results can I expect from taking Saccharomyces boulardii?

You can expect a significant reduction in the incidence of diarrhea and other gastrointestinal symptoms, especially when used preventatively or during treatment.

Also known as: Saccharomyces boulardii, S. boulardii, Saccharomyces turicensis

Overview

Saccharomyces boulardii is a yeast probiotic, genetically and metabolically distinct from other strains of Saccharomyces cerevisiae. It is not a natural inhabitant of the human gut but is derived from tropical fruit skins. Primarily, it's used to prevent and treat gastrointestinal disorders like antibiotic-associated diarrhea (AAD) and traveler's diarrhea. S. boulardii persists longer in the GI tract compared to other strains, modulating gut microbiota, enhancing intestinal barrier function, and producing anti-inflammatory factors. Research on S. boulardii is mature, with numerous randomized controlled trials (RCTs) and meta-analyses supporting its efficacy and safety. It is available in capsule, powder, and liquid forms.

Benefits

Saccharomyces boulardii is effective in preventing antibiotic-associated diarrhea (AAD), with a meta-analysis showing a significant therapeutic efficacy (RR = 0.47, 95% CI: 0.35-0.63, P < 0.001). It also aids in preventing traveler's diarrhea and enteral nutrition-related diarrhea, supported by randomized trials. Secondary benefits include reducing Helicobacter pylori treatment-related symptoms and preventing C. difficile disease recurrences, though more evidence is recommended. Some studies suggest potential benefits in treating irritable bowel syndrome, acute adult diarrhea, Crohn's disease, and giardiasis, but these require further investigation. The benefits are typically observed during treatment, particularly during antibiotic use or other triggering events.

How it works

Saccharomyces boulardii works primarily by modulating the gut microbiota, enhancing the intestinal barrier function, and producing anti-inflammatory factors. It also exhibits antimicrobial properties against certain pathogens. It interacts mainly with the gastrointestinal system, influencing various cytokines and inflammatory pathways, leading to systemic effects through immune system modulation. S. boulardii is not absorbed into the bloodstream, acting locally within the gastrointestinal tract to exert its beneficial effects.

Side effects

Saccharomyces boulardii is generally considered safe, with a low incidence of adverse effects. Common side effects, reported rarely, include bloating, gas, and abdominal pain. No significant uncommon side effects have been consistently reported. Rare side effects include reports of fungemia in severely immunocompromised patients, but this is extremely rare. No significant drug interactions have been reported. It is generally contraindicated in severely immunocompromised patients due to the rare risk of fungemia. Caution is advised in patients with central venous catheters or other invasive devices due to the same risk.

Dosage

The minimum effective dose of Saccharomyces boulardii is typically 250-500 million CFU (colony-forming units) per day. Optimal dosage ranges are between 500-1000 million CFU per day for most indications. There is no established maximum safe dose, but doses above 1000 million CFU per day are not commonly studied. It is best taken during or shortly after meals to enhance survival in the gastrointestinal tract. Available in capsule, powder, or liquid forms, the choice depends on patient preference and specific needs. It is not absorbed systemically, acting locally in the gut.

FAQs

How long does it take to see benefits from Saccharomyces boulardii?

Benefits are typically observed during the course of treatment, particularly when used preventatively during antibiotic use or to manage gastrointestinal symptoms.

Can Saccharomyces boulardii be used with antibiotics?

Yes, it is often used to prevent antibiotic-associated diarrhea (AAD). It helps to maintain gut flora balance during antibiotic treatment.

Is Saccharomyces boulardii safe for immunocompromised patients?

Generally, it is not recommended for severely immunocompromised patients due to a rare risk of fungemia. Caution is advised in such cases.

When is the best time to take Saccharomyces boulardii?

It is best taken during or shortly after meals to enhance its survival and activity in the gastrointestinal tract.

What results can I expect from taking Saccharomyces boulardii?

You can expect a significant reduction in the incidence of diarrhea and other gastrointestinal symptoms, especially when used preventatively or during treatment.

Research Sources

https://www.wjgnet.com/1007-9327/full/v16/i18/2202.htm – This systematic review and meta-analysis of 27 randomized controlled trials (5029 adult patients) found Saccharomyces boulardii to be significantly efficacious and safe in 84% of treatment arms. It demonstrated significant therapeutic efficacy in preventing antibiotic-associated diarrhea (RR = 0.47, 95% CI: 0.35-0.63, P < 0.001).
https://guides.library.harvard.edu/meta-analysis/databases – This resource provides guidance on databases suitable for conducting meta-analyses. It assists researchers in identifying relevant sources for systematic reviews and meta-analyses, ensuring comprehensive coverage of available evidence.
https://pubmed.ncbi.nlm.nih.gov/20458757/ – This study likely provides evidence supporting the use of Saccharomyces boulardii in preventing or treating gastrointestinal disorders. Further review of the study details would be needed to provide a more specific summary of its findings.
https://www.researchgate.net/publication/336586189_Which_Academic_Search_Systems_are_Suitable_for_Systematic_Reviews_or_Meta-Analyses_Evaluating_Retrieval_Qualities_of_Google_Scholar_PubMed_and_26_other_Resources_OPEN_ACCESS – This publication evaluates the retrieval qualities of various academic search systems, including Google Scholar and PubMed, for systematic reviews and meta-analyses. It assesses the suitability of these resources for identifying relevant studies and conducting comprehensive literature reviews.
https://www.mdpi.com/2072-6643/12/2/346 – This study likely provides evidence related to the benefits or mechanisms of action of Saccharomyces boulardii. A detailed review of the study would be needed to provide a more specific summary of its findings and relevance to the overall understanding of the probiotic.